NO842254L - Triazol (2,3-c)(1,3)benzodiazepiner, fremgangsmaate til deres fremstilling, farmasoeytiske preparater som inneholder disse forbindelser, samt deres terapeutiske anvendelse - Google Patents
Triazol (2,3-c)(1,3)benzodiazepiner, fremgangsmaate til deres fremstilling, farmasoeytiske preparater som inneholder disse forbindelser, samt deres terapeutiske anvendelseInfo
- Publication number
- NO842254L NO842254L NO842254A NO842254A NO842254L NO 842254 L NO842254 L NO 842254L NO 842254 A NO842254 A NO 842254A NO 842254 A NO842254 A NO 842254A NO 842254 L NO842254 L NO 842254L
- Authority
- NO
- Norway
- Prior art keywords
- alkyl
- carbamoyl
- alkoxy
- sulfamoyl
- hydroxy
- Prior art date
Links
- 150000001875 compounds Chemical class 0.000 title abstract 8
- 238000000034 method Methods 0.000 title abstract 2
- QWENRTYMTSOGBR-UHFFFAOYSA-N 1H-1,2,3-Triazole Chemical compound C=1C=NNN=1 QWENRTYMTSOGBR-UHFFFAOYSA-N 0.000 title 1
- 229940049706 benzodiazepine Drugs 0.000 title 1
- 150000001557 benzodiazepines Chemical class 0.000 title 1
- 239000000825 pharmaceutical preparation Substances 0.000 title 1
- 238000002360 preparation method Methods 0.000 title 1
- 230000001225 therapeutic effect Effects 0.000 title 1
- 125000000217 alkyl group Chemical group 0.000 abstract 20
- -1 carbamoyl- Chemical group 0.000 abstract 18
- 229910052739 hydrogen Inorganic materials 0.000 abstract 9
- 239000001257 hydrogen Substances 0.000 abstract 9
- 125000003545 alkoxy group Chemical group 0.000 abstract 8
- 229910052736 halogen Inorganic materials 0.000 abstract 8
- 150000002367 halogens Chemical class 0.000 abstract 8
- 125000004453 alkoxycarbonyl group Chemical group 0.000 abstract 6
- 150000002431 hydrogen Chemical group 0.000 abstract 6
- 150000003839 salts Chemical class 0.000 abstract 5
- 125000002861 (C1-C4) alkanoyl group Chemical group 0.000 abstract 4
- 125000002777 acetyl group Chemical group [H]C([H])([H])C(*)=O 0.000 abstract 4
- 125000004414 alkyl thio group Chemical group 0.000 abstract 4
- 125000003754 ethoxycarbonyl group Chemical group C(=O)(OCC)* 0.000 abstract 4
- 125000001160 methoxycarbonyl group Chemical group [H]C([H])([H])OC(*)=O 0.000 abstract 4
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 abstract 4
- 125000002924 primary amino group Chemical group [H]N([H])* 0.000 abstract 4
- 125000001501 propionyl group Chemical group O=C([*])C([H])([H])C([H])([H])[H] 0.000 abstract 4
- 125000002023 trifluoromethyl group Chemical group FC(F)(F)* 0.000 abstract 4
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 abstract 3
- 125000003903 2-propenyl group Chemical group [H]C([*])([H])C([H])=C([H])[H] 0.000 abstract 2
- 125000001494 2-propynyl group Chemical group [H]C#CC([H])([H])* 0.000 abstract 2
- SXIFAEWFOJETOA-UHFFFAOYSA-N 4-hydroxy-butyl Chemical group [CH2]CCCO SXIFAEWFOJETOA-UHFFFAOYSA-N 0.000 abstract 2
- 150000001204 N-oxides Chemical class 0.000 abstract 2
- 229910052783 alkali metal Inorganic materials 0.000 abstract 2
- 150000001340 alkali metals Chemical class 0.000 abstract 2
- 125000005153 alkyl sulfamoyl group Chemical group 0.000 abstract 2
- 125000002947 alkylene group Chemical group 0.000 abstract 2
- 125000000484 butyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 abstract 2
- 125000003917 carbamoyl group Chemical group [H]N([H])C(*)=O 0.000 abstract 2
- 125000004432 carbon atom Chemical group C* 0.000 abstract 2
- 125000002887 hydroxy group Chemical group [H]O* 0.000 abstract 2
- 125000004433 nitrogen atom Chemical group N* 0.000 abstract 2
- 125000001436 propyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])[H] 0.000 abstract 2
- NINIDFKCEFEMDL-UHFFFAOYSA-N Sulfur Chemical compound [S] NINIDFKCEFEMDL-UHFFFAOYSA-N 0.000 abstract 1
- 125000004423 acyloxy group Chemical group 0.000 abstract 1
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 abstract 1
- 238000004519 manufacturing process Methods 0.000 abstract 1
- 239000000203 mixture Substances 0.000 abstract 1
- SYSQUGFVNFXIIT-UHFFFAOYSA-N n-[4-(1,3-benzoxazol-2-yl)phenyl]-4-nitrobenzenesulfonamide Chemical class C1=CC([N+](=O)[O-])=CC=C1S(=O)(=O)NC1=CC=C(C=2OC3=CC=CC=C3N=2)C=C1 SYSQUGFVNFXIIT-UHFFFAOYSA-N 0.000 abstract 1
- 230000003287 optical effect Effects 0.000 abstract 1
- 229910052760 oxygen Inorganic materials 0.000 abstract 1
- 239000001301 oxygen Substances 0.000 abstract 1
- 229910052717 sulfur Inorganic materials 0.000 abstract 1
- 239000011593 sulfur Substances 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D249/00—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms
- C07D249/02—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms not condensed with other rings
- C07D249/08—1,2,4-Triazoles; Hydrogenated 1,2,4-triazoles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D231/00—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
- C07D231/02—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
- C07D231/10—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
- C07D231/12—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
- C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
- C07D233/56—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, attached to ring carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D249/00—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms
- C07D249/02—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms not condensed with other rings
- C07D249/08—1,2,4-Triazoles; Hydrogenated 1,2,4-triazoles
- C07D249/10—1,2,4-Triazoles; Hydrogenated 1,2,4-triazoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D249/00—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms
- C07D249/02—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms not condensed with other rings
- C07D249/08—1,2,4-Triazoles; Hydrogenated 1,2,4-triazoles
- C07D249/10—1,2,4-Triazoles; Hydrogenated 1,2,4-triazoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D249/12—Oxygen or sulfur atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
- C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
- C07D487/04—Ortho-condensed systems
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pharmacology & Pharmacy (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Pulmonology (AREA)
- Immunology (AREA)
- Psychiatry (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Steroid Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US50132883A | 1983-06-06 | 1983-06-06 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| NO842254L true NO842254L (no) | 1984-12-07 |
| NO162070B NO162070B (no) | 1989-07-24 |
| NO162070C NO162070C (no) | 1989-11-01 |
Family
ID=23993078
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NO842254A NO162070C (no) | 1983-06-06 | 1984-06-05 | Analogifremgangsmaate til fremstilling av terapeutisk aktive triazol(2,3-c) (1,3)benzodiazepiner. |
Country Status (17)
| Country | Link |
|---|---|
| EP (1) | EP0129509B1 (no) |
| JP (1) | JPS606689A (no) |
| AT (1) | ATE45740T1 (no) |
| AU (1) | AU574075B2 (no) |
| CA (1) | CA1215044A (no) |
| DD (1) | DD220310A5 (no) |
| DE (1) | DE3479499D1 (no) |
| DK (1) | DK276484A (no) |
| ES (1) | ES8506713A1 (no) |
| FI (1) | FI78098C (no) |
| GR (1) | GR82058B (no) |
| HU (1) | HU190930B (no) |
| IL (1) | IL72015A (no) |
| NO (1) | NO162070C (no) |
| NZ (1) | NZ208373A (no) |
| PT (1) | PT78687A (no) |
| ZA (1) | ZA844186B (no) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| IL84093A (en) * | 1986-10-09 | 1992-09-06 | Ciba Geigy Ag | Aralkyl-4h-1,2,4-triazole derivatives,their preparation and pharmaceutical compositions containing them |
| DE19824673A1 (de) * | 1998-05-26 | 1999-12-02 | Schering Ag | Neue 2,3-Benzodiazepinderivate, deren Herstellung und Verwendung als Arzneimittel |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3539573A (en) * | 1967-03-22 | 1970-11-10 | Jean Schmutz | 11-basic substituted dibenzodiazepines and dibenzothiazepines |
| US4076823A (en) * | 1977-08-18 | 1978-02-28 | E. R. Squibb & Sons, Inc. | Triazolo-2,4-benzodiazepines |
| US4192803A (en) * | 1978-09-15 | 1980-03-11 | American Cyanamid Company | 5H-Pyrrolo[2,1-c][1,4]benzodiazepine derivatives |
| FI824170L (fi) * | 1981-12-07 | 1983-06-08 | Ciba Geigy Ag | Imidazobensodiazepiner, foerfarande foer deras framstaellning, dessa foereningar innehaollande farmaceutiska preparat och deras anvaendning |
-
1984
- 1984-05-29 DE DE8484810264T patent/DE3479499D1/de not_active Expired
- 1984-05-29 EP EP84810264A patent/EP0129509B1/de not_active Expired
- 1984-05-29 AT AT84810264T patent/ATE45740T1/de not_active IP Right Cessation
- 1984-06-04 FI FI842228A patent/FI78098C/fi not_active IP Right Cessation
- 1984-06-04 CA CA000455776A patent/CA1215044A/en not_active Expired
- 1984-06-04 DK DK276484A patent/DK276484A/da not_active Application Discontinuation
- 1984-06-04 PT PT78687A patent/PT78687A/pt not_active IP Right Cessation
- 1984-06-04 GR GR74912A patent/GR82058B/el unknown
- 1984-06-04 IL IL72015A patent/IL72015A/xx unknown
- 1984-06-05 ES ES533135A patent/ES8506713A1/es not_active Expired
- 1984-06-05 HU HU842181A patent/HU190930B/hu unknown
- 1984-06-05 AU AU29106/84A patent/AU574075B2/en not_active Ceased
- 1984-06-05 NZ NZ208373A patent/NZ208373A/en unknown
- 1984-06-05 ZA ZA844186A patent/ZA844186B/xx unknown
- 1984-06-05 DD DD84263805A patent/DD220310A5/de not_active IP Right Cessation
- 1984-06-05 NO NO842254A patent/NO162070C/no unknown
- 1984-06-06 JP JP59114697A patent/JPS606689A/ja active Granted
Also Published As
| Publication number | Publication date |
|---|---|
| ES533135A0 (es) | 1985-08-01 |
| ES8506713A1 (es) | 1985-08-01 |
| EP0129509A3 (en) | 1985-09-11 |
| FI842228A0 (fi) | 1984-06-04 |
| ZA844186B (en) | 1985-02-27 |
| IL72015A (en) | 1987-12-31 |
| EP0129509B1 (de) | 1989-08-23 |
| ATE45740T1 (de) | 1989-09-15 |
| DE3479499D1 (en) | 1989-09-28 |
| GR82058B (no) | 1984-12-13 |
| NO162070C (no) | 1989-11-01 |
| JPS606689A (ja) | 1985-01-14 |
| NZ208373A (en) | 1987-02-20 |
| DD220310A5 (de) | 1985-03-27 |
| HU190930B (en) | 1986-12-28 |
| PT78687A (en) | 1984-07-01 |
| IL72015A0 (en) | 1984-10-31 |
| AU2910684A (en) | 1984-12-13 |
| CA1215044A (en) | 1986-12-09 |
| HUT34488A (en) | 1985-03-28 |
| AU574075B2 (en) | 1988-06-30 |
| DK276484A (da) | 1984-12-07 |
| DK276484D0 (da) | 1984-06-04 |
| FI842228A7 (fi) | 1984-12-07 |
| FI78098B (fi) | 1989-02-28 |
| JPH0354669B2 (no) | 1991-08-20 |
| EP0129509A2 (de) | 1984-12-27 |
| NO162070B (no) | 1989-07-24 |
| FI78098C (fi) | 1989-06-12 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JO1351B1 (en) | Chemical compounds | |
| WO1999042465A3 (en) | Sulphonamide derivatives being 5-ht6 receptor antagonists and process for their preparation | |
| DE3264861D1 (en) | Modified d-retro cyclic hexapeptide somatostatin analogs, process for their preparation and pharmaceutical compositions containing them | |
| NO801866L (no) | Pyrazolokinoliner, fremgangsmaate til deres fremstilling, farmasoeytiske preparater inneholdende disse forbindelser, samt deres terapeutiske anvendelse | |
| AU2413995A (en) | Bicyclic amidine derivatives as inhibitors of nitric oxide synthetase | |
| IE872646L (en) | 7-((meta-substituted) phenylglycine)¹1-carba-1-dethiacephalosporins | |
| NO842254L (no) | Triazol (2,3-c)(1,3)benzodiazepiner, fremgangsmaate til deres fremstilling, farmasoeytiske preparater som inneholder disse forbindelser, samt deres terapeutiske anvendelse | |
| GB8823475D0 (en) | Chemical compounds | |
| IE880306L (en) | Pyridopyrroloquinolines and intermediates thereof | |
| DK210387D0 (da) | Heterocykliske forbindelser og fremgangsmaade til deres fremstilling samt farmaceutiske midler indeholdende disse | |
| ES8307812A1 (es) | Un procedimiento para la preparacion de nuevos amidin derivados del acido clavulawilo. | |
| GR3023653T3 (en) | N(1) substituted pyrazino Ä2,3-cÜ-1,2,6-thiadiazine 2,2-dioxides and their use as pharmaceuticals |